Safety and Efficacy of SHR4640 Combined with Febuxostat for Primary Hyperuricemia: a Multicenter, Randomized, Double-Blind, Phase II Study.
Therapeutic Advances in Musculoskeletal Disease(2022)
Key words
febuxostat,gout,primary hyperuricemia,SHR4640,URAT-1 inhibitor,XOIs
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined